Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $9.06 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.12.
Market Cap
9.06T
Revenue
4.66T
Profits
184.42B
PE Ratio
49.12
Profit Margin
3.96%
Dividend Yield
0.39%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | 1.12% | 1,793,377 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 618.63B | -0.34% | 2,525,043 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 429.87B | -1.19% | 2,006,268 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 368.33B | -1.73% | 2,173,999 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 316.66B | -0.09% | 3,745,033 | 66.57B |
| 6 | NVS | Novartis AG | 292.81B | -0.13% | 783,810 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 251.40B | -0.67% | 1,552,666 | 61.37B |
| 8 | AMGN | Amgen Inc. | 217.31B | -1.44% | 1,392,111 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 212.71B | -0.44% | 695,968 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 201.07B | 2.71% | 8,701,202 | 50.34B |
| 11 | ABT | Abbott Laboratories | 186.09B | 1.73% | 4,438,171 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 160.78B | -1.67% | 3,677,329 | 30.46B |
| 13 | PFE | Pfizer Inc. | 148.25B | 0.77% | 28,123,479 | 63.70B |
| 14 | DHR | Danaher Corporation | 139.50B | -0.61% | 1,373,455 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 132.41B | -0.10% | 1,550,729 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 130.41B | 0.33% | 4,802,290 | 49.19B |
| 17 | SYK | Stryker Corporation | 128.63B | -0.50% | 933,185 | 25.84B |
| 18 | CVS | CVS Health Corporation | 124.05B | -2.15% | 5,766,349 | 412.65B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 122.52B | -0.30% | 454,768 | 12.59B |
| 20 | MDT | Medtronic plc | 110.25B | 0.16% | 2,250,954 | 36.36B |
| 21 | GSK | GSK plc | 103.36B | 1.30% | 1,534,456 | 44.05B |
| 22 | SNY | Sanofi | 103.06B | 0.27% | 3,282,593 | 55.89B |
| 23 | MCK | McKesson Corporation | 100.80B | -1.45% | 1,131,664 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 88.37B | -0.36% | 498,121 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 84.60B | -0.30% | 364,475 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.41B | -0.44% | 212,279 | 15.53B |
| 27 | CI | The Cigna Group | 72.29B | 1.13% | 1,457,651 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 71.87B | 3.88% | 11,963,316 | 21.00B |
| 29 | COR | Cencora, Inc. | 61.06B | 0.86% | 897,866 | 332.77B |
| 30 | CAH | Cardinal Health, Inc. | 55.77B | -0.47% | 746,149 | 250.74B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 54.98B | 1.64% | 3,361,303 | 28.42B |
| 32 | ARGX | argenx SE | 54.05B | -0.01% | 142,214 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 51.29B | 0.01% | 1,088,271 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 48.73B | 3.62% | 1,786,626 | 22.48B |
| 35 | MDLN | Medline Inc. | 46.40B | -3.72% | 5,019,246 | 29.94B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 46.31B | 0.51% | 316,770 | 4.55B |
| 37 | HLN | Haleon plc | 43.38B | 0.55% | 4,979,981 | 14.80B |
| 38 | HUM | Humana Inc. | 43.34B | -0.79% | 467,186 | 145.68B |
| 39 | RVMD | Revolution Medicines, Inc. | 41.64B | -0.73% | 1,043,416 | - |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 40.38B | -0.20% | 1,585,949 | 17.32B |
| 41 | A | Agilent Technologies, Inc. | 39.65B | -0.50% | 346,163 | 7.23B |
| 42 | WAT | Waters Corporation | 38.88B | -1.01% | 398,880 | 4.64B |
| 43 | NTRA | Natera, Inc. | 38.08B | -3.19% | 938,578 | 2.50B |
| 44 | IQV | IQVIA Holdings Inc. | 37.98B | -2.24% | 603,215 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 37.32B | 0.20% | 168,733 | 6.13B |
| 46 | VEEV | Veeva Systems Inc. | 34.93B | 0.70% | 788,301 | 3.32B |
| 47 | ALC | Alcon Inc. | 34.27B | -1.30% | 942,761 | 10.63B |
| 48 | RPRX | Royalty Pharma plc | 32.96B | -0.88% | 1,098,984 | 2.54B |
| 49 | RMD | ResMed Inc. | 32.40B | 0.25% | 1,018,812 | 5.54B |
| 50 | ZTS | Zoetis Inc. | 32.23B | 3.33% | 11,820,207 | 9.53B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 31.81B | 0.27% | 1,809,084 | 21.27B |
| 52 | CNC | Centene Corporation | 31.74B | -4.08% | 2,549,637 | 180.30B |
| 53 | DXCM | DexCom, Inc. | 31.35B | 0.52% | 1,918,326 | 4.97B |
| 54 | BIIB | Biogen Inc. | 30.39B | -0.47% | 369,459 | 10.03B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.38B | -4.02% | 1,103,827 | 4.80B |
| 56 | ILMN | Illumina, Inc. | 28.62B | -5.17% | 2,074,558 | 4.49B |
| 57 | INSM | Insmed Incorporated | 28.43B | 32.48% | 8,770,266 | 1.14B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.37B | -0.39% | 47,009 | 4.13B |
| 59 | DGX | Quest Diagnostics Incorporated | 26.17B | 0.53% | 276,776 | 11.56B |
| 60 | PHG | Koninklijke Philips N.V. | 25.93B | -1.09% | 575,950 | 20.18B |
| 61 | LH | Labcorp Holdings Inc. | 25.55B | 0.35% | 162,756 | 14.35B |
| 62 | ROIV | Roivant Sciences Ltd. | 25.24B | 1.42% | 3,516,860 | 7.53M |
| 63 | WST | West Pharmaceutical Services, Inc. | 24.46B | -0.97% | 181,412 | 3.33B |
| 64 | INCY | Incyte Corporation | 23.65B | -2.59% | 1,224,253 | 5.82B |
| 65 | BNTX | BioNTech SE | 22.76B | -1.70% | 871,469 | 3.03B |
| 66 | UTHR | United Therapeutics Corporation | 22.60B | 1.51% | 636,072 | 3.15B |
| 67 | STE | STERIS plc | 22.42B | -1.16% | 861,545 | 6.04B |
| 68 | MRNA | Moderna, Inc. | 21.70B | -3.37% | 3,632,571 | 2.23B |
| 69 | GH | Guardant Health, Inc. | 21.38B | -2.36% | 612,232 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 20.90B | -0.81% | 332,623 | 21.81B |
| 71 | VTRS | Viatris Inc. | 19.89B | -3.23% | 9,512,437 | 14.74B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.41B | -1.66% | 1,317,158 | 8.51B |
| 73 | GMAB | Genmab A/S | 17.94B | -1.50% | 2,256,309 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 16.86B | -0.73% | 225,152 | 4.60B |
| 75 | ASND | Ascendis Pharma A/S | 16.40B | 1.90% | 241,462 | 998.25M |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.29B | -0.75% | 760,555 | 3.37B |
| 77 | MEDP | Medpace Holdings, Inc. | 16.23B | -1.08% | 58,398 | 2.78B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 16.10B | 0.46% | 647,855 | 579.96M |
| 79 | COO | The Cooper Companies, Inc. | 14.42B | -1.23% | 1,011,259 | 4.23B |
| 80 | SOLV | Solventum Corporation | 14.13B | -5.13% | 1,015,877 | 8.31B |
| 81 | BAX | Baxter International Inc. | 14.10B | -0.18% | 2,996,790 | 11.47B |
| 82 | EXEL | Exelixis, Inc. | 13.21B | -7.28% | 2,875,893 | 2.44B |
| 83 | PEN | Penumbra, Inc. | 12.81B | 0.61% | 94,625 | 1.50B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 12.81B | -2.87% | 1,051,666 | 14.37B |
| 85 | FMS | Fresenius Medical Care AG | 12.79B | 0.88% | 700,457 | 22.19B |
| 86 | RVTY | Revvity, Inc. | 12.61B | -1.75% | 457,745 | 2.91B |
| 87 | EHC | Encompass Health Corporation | 12.47B | 13.33% | 864,330 | 6.21B |
| 88 | SNN | Smith & Nephew plc | 12.43B | -1.69% | 699,967 | 6.30B |
| 89 | ICLR | ICON Public Limited Company | 12.41B | -1.65% | 231,208 | 8.29B |
| 90 | CRL | Charles River Laboratories International, Inc. | 12.37B | -0.58% | 454,520 | 4.00B |
| 91 | ALGN | Align Technology, Inc. | 12.34B | -1.48% | 293,546 | 4.14B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.11B | -1.38% | 458,106 | 669.50M |
| 93 | ELAN | Elanco Animal Health Incorporated | 11.94B | -8.83% | 11,416,142 | 5.02B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | 0.18% | 126,033 | 1.28B |
| 95 | CORT | Corcept Therapeutics Incorporated | 11.67B | -2.44% | 371,103 | 830.81M |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.67B | 0.75% | 1,371,830 | 3.24B |
| 97 | DVA | DaVita Inc. | 11.51B | -4.35% | 866,875 | 14.01B |
| 98 | TECH | Bio-Techne Corporation | 11.21B | -0.04% | 1,332,467 | 1.21B |
| 99 | ABVX | ABIVAX Société Anonyme | 10.95B | 2.53% | 495,249 | 5.67M |
| 100 | AXSM | Axsome Therapeutics, Inc. | 10.93B | -0.24% | 161,892 | 708.24M |
| 101 | CYTK | Cytokinetics, Incorporated | 10.86B | 1.48% | 842,821 | 105.82M |
| 102 | GMED | Globus Medical, Inc. | 10.81B | -1.17% | 744,666 | 3.10B |
| 103 | SMMT | Summit Therapeutics Inc. | 10.75B | -0.37% | 1,108,706 | - |
| 104 | ENSG | The Ensign Group, Inc. | 10.48B | 1.50% | 149,138 | 5.49B |
| 105 | UHS | Universal Health Services, Inc. | 10.33B | -0.55% | 173,440 | 18.11B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 10.32B | 15.99% | 1,006,318 | 7.46M |
| 107 | RDY | Dr. Reddy's Laboratories Limited | 10.29B | -0.41% | 1,297,357 | 3.50B |
| 108 | APGE | Apogee Therapeutics, Inc. | 10.10B | 0.20% | 845,678 | - |
| 109 | MOH | Molina Healthcare, Inc. | 10.03B | -1.30% | 286,504 | 42.47B |
| 110 | GKOS | Glaukos Corporation | 10.02B | -0.57% | 204,577 | 612.84M |
| 111 | HALO | Halozyme Therapeutics, Inc. | 9.97B | 0.51% | 631,605 | 1.51B |
| 112 | HSIC | Henry Schein, Inc. | 9.89B | -0.95% | 490,297 | 13.60B |
| 113 | KRYS | Krystal Biotech, Inc. | 9.61B | -0.36% | 73,050 | 440.48M |
| 114 | PODD | Insulet Corporation | 9.51B | 2.92% | 2,112,800 | 3.05B |
| 115 | PTGX | Protagonist Therapeutics, Inc. | 9.37B | 6.14% | 431,473 | 281.99M |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 9.14B | -1.78% | 169,545 | 2.59B |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 9.09B | 0.92% | 1,112,491 | 874.09M |
| 118 | SYRE | Spyre Therapeutics, Inc. | 9.04B | -1.74% | 227,681 | - |
| 119 | RGEN | Repligen Corporation | 8.97B | 0.26% | 695,251 | 785.10M |
| 120 | AVTR | Avantor, Inc. | 8.92B | -1.27% | 4,745,114 | 6.56B |
| 121 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.92B | 0.09% | 1,207,111 | 42.16M |
| 122 | HQY | HealthEquity, Inc. | 8.74B | 0.09% | 190,583 | 1.34B |
| 123 | ATR | AptarGroup, Inc. | 8.64B | -0.59% | 291,011 | 3.93B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 8.63B | -0.51% | 248,572 | 105.00M |
| 125 | QGEN | Qiagen N.V. | 8.61B | -0.76% | 1,715,650 | 2.10B |
| 126 | PCVX | Vaxcyte, Inc. | 8.38B | 3.74% | 653,263 | - |
| 127 | TEM | Tempus AI, Inc. | 8.36B | -0.73% | 1,608,141 | 1.43B |
| 128 | ALKS | Alkermes plc | 8.14B | -2.24% | 579,814 | 1.67B |
| 129 | OSCR | Oscar Health, Inc. | 8.08B | -10.86% | 12,140,393 | 15.32B |
| 130 | IMVT | Immunovant, Inc. | 8.08B | -0.31% | 442,663 | - |
| 131 | LQDA | Liquidia Corporation | 7.93B | 0.11% | 299,945 | 288.07M |
| 132 | BRKR | Bruker Corporation | 7.82B | -2.10% | 960,112 | 3.50B |
| 133 | IBRX | ImmunityBio, Inc. | 7.79B | 1.38% | 5,250,876 | 165.79M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.54B | -1.11% | 331,896 | 239.92M |
| 135 | PACS | PACS Group, Inc. | 7.45B | 3.12% | 636,474 | 5.55B |
| 136 | CHE | Chemed Corporation | 7.14B | 0.41% | 64,678 | 2.60B |
| 137 | COGT | Cogent Biosciences, Inc. | 7.07B | -2.08% | 443,785 | - |
| 138 | TGTX | TG Therapeutics, Inc. | 7.07B | 0.04% | 688,185 | 799.54M |
| 139 | TWST | Twist Bioscience Corporation | 6.96B | -3.49% | 949,833 | 431.80M |
| 140 | GRFS | Grifols, S.A. | 6.95B | -0.57% | 168,159 | 8.48B |
| 141 | HIMS | Hims & Hers Health, Inc. | 6.93B | -5.34% | 4,712,449 | 2.37B |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.58B | -0.45% | 1,249,785 | 1.56B |
| 143 | CGON | CG Oncology, Inc. | 6.57B | 2.91% | 541,792 | 6.23M |
| 144 | BLTE | Belite Bio, Inc | 6.36B | 2.04% | 81,979 | - |
| 145 | ERAS | Erasca, Inc. | 6.34B | -1.88% | 1,188,675 | - |
| 146 | SRRK | Scholar Rock Holding Corporation | 6.31B | 9.92% | 834,256 | - |
| 147 | XENE | Xenon Pharmaceuticals Inc. | 6.21B | -0.14% | 175,660 | 7.50M |
| 148 | TFX | Teleflex Incorporated | 6.19B | 2.28% | 826,117 | 2.25B |
| 149 | HNGE | Hinge Health, Inc. | 6.19B | -1.00% | 872,505 | 720.06M |
| 150 | LGND | Ligand Pharmaceuticals Incorporated | 6.15B | 2.54% | 215,394 | 290.54M |
| 151 | TVTX | Travere Therapeutics, Inc. | 6.03B | 1.99% | 1,546,004 | 591.33M |
| 152 | DNTH | Dianthus Therapeutics, Inc. | 5.99B | -4.81% | 332,816 | 1.90M |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.92B | -2.75% | 186,314 | 840.85M |
| 154 | DFTX | Definium Therapeutics, Inc. | 5.92B | 0.47% | 744,434 | - |
| 155 | PTCT | PTC Therapeutics, Inc. | 5.88B | 1.81% | 454,803 | 1.01B |
| 156 | BLCO | Bausch + Lomb Corporation | 5.88B | -1.85% | 185,054 | 5.32B |
| 157 | ORKA | Oruka Therapeutics, Inc. | 5.84B | -0.31% | 147,573 | - |
| 158 | TXG | 10x Genomics, Inc. | 5.81B | -3.62% | 1,263,251 | 638.78M |
| 159 | MIRM | Mirum Pharmaceuticals, Inc. | 5.80B | -10.04% | 2,035,244 | 618.07M |
| 160 | AMRX | Amneal Pharmaceuticals, Inc. | 5.78B | -1.84% | 537,266 | 3.12B |
| 161 | STVN | Stevanato Group S.p.A. | 5.50B | 0.25% | 267,799 | 1.40B |
| 162 | CAI | Caris Life Sciences, Inc. | 5.50B | 18.30% | 7,576,214 | 989.61M |
| 163 | SHC | Sotera Health Company | 5.38B | 4.89% | 2,822,573 | 1.22B |
| 164 | RDNT | RadNet, Inc. | 5.31B | 0.78% | 195,343 | 2.14B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.25B | 0.88% | 498,461 | 1.58B |
| 166 | MMED | MiniMed Group, Inc. | 5.21B | -0.13% | 191,281 | 3.10B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.04B | -0.65% | 542,582 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.97B | 0.07% | 2,037,459 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.80B | -1.72% | 611,325 | - |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.73B | -2.31% | 675,390 | - |
| 171 | INDV | Indivior Pharmaceuticals, Inc. | 4.62B | 1.06% | 1,166,711 | 1.33B |
| 172 | WAY | Waystar Holding Corp. | 4.55B | 1.45% | 1,367,724 | 1.21B |
| 173 | NVST | Envista Holdings Corporation | 4.54B | -2.62% | 3,818,230 | 2.86B |
| 174 | PBLS | Parabilis Medicines, Inc. | 4.53B | 1.95% | 165,902 | - |
| 175 | MANE | Veradermics, Incorporated | 4.53B | -2.71% | 238,422 | - |
| 176 | CELC | Celcuity Inc. | 4.52B | -0.33% | 272,971 | - |
| 177 | BLLN | BillionToOne, Inc. | 4.29B | -39.39% | 2,799,938 | 397.41M |
| 178 | RLAY | Relay Therapeutics, Inc. | 4.28B | -0.36% | 1,374,600 | 10.68M |
| 179 | ITGR | Integer Holdings Corporation | 4.25B | -0.04% | 869,192 | 1.84B |
| 180 | LIVN | LivaNova PLC | 4.22B | -1.63% | 360,120 | 1.47B |
| 181 | ELVN | Enliven Therapeutics, Inc. | 4.22B | 1.29% | 898,834 | - |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.18B | 0.31% | 827,010 | 56.99M |
| 183 | ICUI | ICU Medical, Inc. | 4.14B | -0.52% | 163,864 | 2.16B |
| 184 | LFST | LifeStance Health Group, Inc. | 4.12B | 2.51% | 4,582,088 | 1.58B |
| 185 | IRTC | iRhythm Holdings, Inc. | 4.11B | 0.55% | 544,541 | 787.85M |
| 186 | CON | Concentra Group Holdings Parent, Inc. | 3.93B | -0.26% | 474,591 | 2.23B |
| 187 | DNLI | Denali Therapeutics Inc. | 3.92B | 1.27% | 894,697 | - |
| 188 | VKTX | Viking Therapeutics, Inc. | 3.89B | -0.54% | 704,035 | - |
| 189 | HAE | Haemonetics Corporation | 3.89B | 2.32% | 684,298 | 1.35B |
| 190 | DOCS | Doximity, Inc. | 3.80B | -2.27% | 10,420,359 | 644.86M |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 3.78B | -3.78% | 743,428 | 308.08M |
| 192 | VCYT | Veracyte, Inc. | 3.72B | 0.22% | 460,924 | 561.90M |
| 193 | LEGN | Legend Biotech Corporation | 3.71B | 0.68% | 929,901 | 1.14B |
| 194 | GPCR | Structure Therapeutics Inc. | 3.67B | 2.14% | 164,551 | - |
| 195 | TLX | Telix Pharmaceuticals Limited | 3.61B | 2.11% | 42,041 | 803.79M |
| 196 | OPCH | Option Care Health, Inc. | 3.56B | 0.38% | 1,555,546 | 5.69B |
| 197 | OGN | Organon & Co. | 3.56B | -0.11% | 708,481 | 6.13B |
| 198 | ALMS | Alumis Inc. | 3.51B | 1.55% | 269,173 | 8.40M |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.50B | 0.64% | 198,407 | 234.13M |
| 200 | NHC | National HealthCare Corporation | 3.50B | 1.06% | 61,559 | 1.53B |
| 201 | BKD | Brookdale Senior Living Inc. | 3.48B | 1.00% | 1,358,822 | 3.00B |
| 202 | RCUS | Arcus Biosciences, Inc. | 3.47B | -0.51% | 1,760,190 | 117.00M |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.32B | -2.16% | 1,870,615 | 463.98M |
| 204 | NAMS | NewAmsterdam Pharma Company N.V. | 3.24B | 1.06% | 853,698 | 7.12M |
| 205 | CLDX | Celldex Therapeutics, Inc. | 3.24B | 0.39% | 403,730 | 865.00K |
| 206 | WRBY | Warby Parker Inc. | 3.17B | -11.79% | 3,910,447 | 890.57M |
| 207 | QURE | uniQure N.V. | 3.10B | 0.90% | 617,262 | 18.67M |
| 208 | MBX | MBX Biosciences, Inc. | 3.10B | -3.64% | 276,572 | - |
| 209 | IRON | Disc Medicine, Inc. | 3.00B | -0.83% | 137,560 | - |
| 210 | IMNM | Immunome, Inc. | 2.90B | 0.43% | 425,150 | 4.02M |
| 211 | ACHC | Acadia Healthcare Company, Inc. | 2.86B | -4.59% | 746,338 | 3.37B |
| 212 | RGC | Regencell Bioscience Holdings Limited | 2.85B | -1.87% | 98,083 | - |
| 213 | KOD | Kodiak Sciences Inc. | 2.85B | 4.75% | 351,901 | - |
| 214 | ALHC | Alignment Healthcare, Inc. | 2.84B | 0.04% | 2,909,820 | 4.58B |
| 215 | GRAL | GRAIL, Inc. | 2.80B | -15.37% | 1,292,928 | 165.26M |
| 216 | TARS | Tarsus Pharmaceuticals, Inc. | 2.76B | 4.55% | 904,407 | 606.33M |
| 217 | TMDX | TransMedics Group, Inc. | 2.76B | 3.90% | 617,849 | 668.47M |
| 218 | SUPN | Supernus Pharmaceuticals, Inc. | 2.75B | 0.71% | 412,608 | 830.44M |
| 219 | IOVA | Iovance Biotherapeutics, Inc. | 2.74B | 41.36% | 56,901,580 | 324.97M |
| 220 | BEAM | Beam Therapeutics Inc. | 2.73B | 0.92% | 624,583 | 156.04M |
| 221 | PLSE | Pulse Biosciences, Inc. | 2.70B | 2.90% | 121,430 | 751.00K |
| 222 | XRAY | DENTSPLY SIRONA Inc. | 2.68B | -3.05% | 2,988,203 | 3.68B |
| 223 | ATAI | AtaiBeckley Inc. | 2.67B | -0.21% | 2,694,092 | 3.49M |
| 224 | PRVA | Privia Health Group, Inc. | 2.66B | -11.85% | 2,672,310 | 2.36B |
| 225 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.64B | 8.65% | 2,385,905 | -665.00K |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.60B | -1.98% | 1,070,979 | - |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.56B | -1.63% | 246,209 | 36.77M |
| 228 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | 3.49% | 740,879 | 717.00M |
| 229 | GRDN | Guardian Pharmacy Services, Inc. | 2.51B | -2.22% | 122,349 | 1.46B |
| 230 | PGEN | Precigen, Inc. | 2.49B | 0.80% | 4,162,555 | 85.72M |
| 231 | NKTR | Nektar Therapeutics | 2.48B | 0.31% | 236,462 | 55.63M |
| 232 | PBH | Prestige Consumer Healthcare Inc. | 2.47B | -1.76% | 493,908 | 1.10B |
| 233 | CLOV | Clover Health Investments, Corp. | 2.45B | 12.44% | 9,104,226 | 2.48B |
| 234 | UFPT | UFP Technologies, Inc. | 2.45B | -1.75% | 101,266 | 631.64M |
| 235 | ESTA | Establishment Labs Holdings Inc. | 2.45B | -8.89% | 509,937 | 245.82M |
| 236 | PHVS | Pharvaris N.V. | 2.44B | 4.58% | 231,103 | - |
| 237 | NEOG | Neogen Corporation | 2.44B | -1.75% | 839,382 | 870.40M |
| 238 | VRDN | Viridian Therapeutics, Inc. | 2.44B | 4.84% | 2,927,232 | 71.13M |
| 239 | PGNY | Progyny, Inc. | 2.42B | -1.59% | 807,546 | 1.29B |
| 240 | COAG | Hemab Therapeutics Holdings, Inc. | 2.41B | 3.20% | 167,380 | - |
| 241 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.39B | 3.09% | 1,994,728 | 940.61M |
| 242 | AXGN | Axogen, Inc. | 2.38B | -2.01% | 219,834 | 251.17M |
| 243 | ZLAB | Zai Lab Limited | 2.38B | 15.11% | 934,679 | 449.61M |
| 244 | KLRA | Kailera Therapeutics, Inc. | 2.37B | 0.88% | 70,236 | - |
| 245 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | 0.26% | 226,949 | - |
| 246 | CDNA | CareDx, Inc. | 2.35B | -0.31% | 328,738 | 458.09M |
| 247 | HTFL | HeartFlow, Inc. | 2.35B | 0.11% | 204,152 | 191.42M |
| 248 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -1.60% | 2,772,346 | - |
| 249 | VERA | Vera Therapeutics, Inc. | 2.28B | 4.61% | 1,282,195 | - |
| 250 | VCEL | Vericel Corporation | 2.28B | -1.94% | 104,856 | 306.30M |
| 251 | URGN | UroGen Pharma Ltd. | 2.27B | 0.17% | 670,789 | 188.73M |
| 252 | ADMA | ADMA Biologics, Inc. | 2.25B | 7.88% | 3,574,984 | 512.28M |
| 253 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | 0.52% | 367,827 | 959.90M |
| 254 | BFLY | Butterfly Network, Inc. | 2.22B | -0.77% | 2,356,597 | 112.14M |
| 255 | BHC | Bausch Health Companies Inc. | 2.22B | -5.56% | 2,183,541 | 10.85B |
| 256 | SION | Sionna Therapeutics, Inc. | 2.21B | 3.53% | 379,024 | - |
| 257 | PVLA | Palvella Therapeutics, Inc. | 2.19B | -1.66% | 47,738 | - |
| 258 | ADUS | Addus HomeCare Corporation | 2.17B | 2.00% | 101,224 | 1.48B |
| 259 | NUVB | Nuvation Bio Inc. | 2.17B | -2.35% | 5,777,276 | 169.90M |
| 260 | BHVN | Biohaven Ltd. | 2.17B | 5.50% | 1,078,990 | - |
| 261 | RAPP | Rapport Therapeutics, Inc. | 2.14B | 5.00% | 189,850 | 20.00M |
| 262 | MD | Pediatrix Medical Group, Inc. | 2.10B | 2.00% | 477,784 | 1.95B |
| 263 | HCM | HUTCHMED (China) Limited | 2.08B | 1.88% | 15,590 | 549.12M |
| 264 | GHRS | GH Research PLC | 2.06B | 3.02% | 341,734 | - |
| 265 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 5.33% | 1,081,707 | 311.51M |
| 266 | STOK | Stoke Therapeutics, Inc. | 2.05B | -0.31% | 407,361 | 27.59M |
| 267 | WGS | GeneDx Holdings Corp. | 2.05B | -1.86% | 418,662 | 454.43M |
| 268 | MESO | Mesoblast Limited | 2.05B | 4.31% | 161,375 | 65.38M |
| 269 | ATRC | AtriCure, Inc. | 2.04B | 2.08% | 373,351 | 569.62M |
| 270 | TSHA | Taysha Gene Therapies, Inc. | 2.04B | -1.39% | 988,001 | 7.47M |
| 271 | AVAH | Aveanna Healthcare Holdings Inc. | 2.03B | 0.16% | 644,343 | 2.52B |
| 272 | NEO | NeoGenomics, Inc. | 2.01B | -0.51% | 931,985 | 766.30M |
| 273 | ZBIO | Zenas BioPharma, Inc. | 2.01B | -0.31% | 432,796 | 10.00M |
| 274 | NBTX | Nanobiotix S.A. | 1.99B | -4.21% | 119,956 | 38.27M |
| 275 | ABCL | AbCellera Biologics Inc. | 1.95B | 7.85% | 6,359,952 | 66.17M |
| 276 | SGRY | Surgery Partners, Inc. | 1.93B | -2.87% | 647,822 | 3.34B |
| 277 | AGIO | Agios Pharmaceuticals, Inc. | 1.92B | 1.39% | 493,527 | 98.34M |
| 278 | OCUL | Ocular Therapeutix, Inc. | 1.92B | 2.82% | 893,038 | 52.06M |
| 279 | ALMR | Alamar Biosciences, Inc. | 1.91B | -2.70% | 112,527 | 87.16M |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.89B | 1.81% | 210,171 | 367.34M |
| 281 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.24% | 1,443,754 | - |
| 282 | BRVE | Braveheart Bio, Inc. | 1.85B | 66.67% | 2,077,649 | - |
| 283 | DMRA | Damora Therapeutics, Inc. | 1.84B | -2.82% | 498,206 | - |
| 284 | NVCR | NovoCure Limited | 1.84B | -1.56% | 464,116 | 699.19M |
| 285 | LMAT | LeMaitre Vascular, Inc. | 1.83B | 1.19% | 338,395 | 262.43M |
| 286 | OBX | Obsidian Therapeutics, Inc. | 1.82B | 3.47% | 5,633 | - |
| 287 | CMPS | COMPASS Pathways plc | 1.81B | -1.10% | 1,676,748 | - |
| 288 | KARD | Kardigan, Inc. | 1.80B | -0.64% | 107,102 | - |
| 289 | BCAX | Bicara Therapeutics Inc. | 1.78B | 4.81% | 460,509 | - |
| 290 | SEPN | Septerna, Inc. | 1.78B | 1.65% | 95,461 | 72.26M |
| 291 | GENB | Generate Biomedicines, Inc. | 1.77B | -4.49% | 620,645 | 26.48M |
| 292 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | -1.56% | 576,025 | 252.25M |
| 293 | SRPT | Sarepta Therapeutics, Inc. | 1.75B | 3.83% | 2,657,813 | 1.97B |
| 294 | LKFT | Lakefront Biotherapeutics NV | 1.74B | -0.44% | 283,509 | 1.20B |
| 295 | ANIP | ANI Pharmaceuticals, Inc. | 1.73B | 2.16% | 436,256 | 923.71M |
| 296 | INSP | Inspire Medical Systems, Inc. | 1.72B | -0.93% | 290,514 | 898.74M |
| 297 | PRGO | Perrigo Company plc | 1.72B | -6.63% | 2,011,228 | 4.14B |
| 298 | TRLV | Trulieve Cannabis Corp. | 1.71B | 5.33% | 556,140 | 1.17B |
| 299 | FTRE | Fortrea Holdings Inc. | 1.70B | -6.14% | 742,663 | 2.68B |
| 300 | RXRX | Recursion Pharmaceuticals, Inc. | 1.68B | -0.95% | 8,877,074 | 54.86M |
| 301 | ZYME | Zymeworks Inc. | 1.67B | -0.96% | 177,519 | 81.26M |
| 302 | IMCR | Immunocore Holdings plc | 1.66B | -1.68% | 231,280 | 430.78M |
| 303 | BLFS | BioLife Solutions, Inc. | 1.66B | 0.24% | 207,131 | 101.66M |
| 304 | OMCL | Omnicell, Inc. | 1.65B | -2.14% | 170,847 | 1.25B |
| 305 | ANAB | AnaptysBio, Inc. | 1.62B | -0.56% | 129,128 | 232.39M |
| 306 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.60B | -3.04% | 584,992 | 204.73M |
| 307 | ARDT | Ardent Health, Inc. | 1.60B | 1.25% | 340,482 | 6.41B |
| 308 | TRAX | First Tracks Biotherapeutics, Inc. | 1.59B | -3.00% | 181,231 | - |
| 309 | AGL | agilon health, inc. | 1.59B | -12.37% | 709,953 | 5.92B |
| 310 | TYRA | Tyra Biosciences, Inc. | 1.58B | 2.99% | 361,543 | - |
| 311 | AAPG | Ascentage Pharma Group International | 1.57B | 1.11% | 2,284 | 82.08M |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.56B | 1.49% | 76,779 | 20.00M |
| 313 | INVA | Innoviva, Inc. | 1.56B | 3.17% | 623,251 | 440.00M |
| 314 | ASTH | Astrana Health, Inc. | 1.55B | -3.66% | 353,505 | 3.53B |
| 315 | NTLA | Intellia Therapeutics, Inc. | 1.55B | 1.37% | 2,505,499 | 59.51M |
| 316 | HCSG | Healthcare Services Group, Inc. | 1.53B | -2.19% | 583,933 | 1.86B |
| 317 | ENOV | Enovis Corporation | 1.48B | -14.55% | 1,518,799 | 2.30B |
| 318 | INNV | InnovAge Holding Corp. | 1.48B | -1.67% | 84,695 | 949.17M |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.48B | 2.05% | 321,657 | - |
| 320 | CNMD | CONMED Corporation | 1.48B | 0.18% | 248,597 | 1.37B |
| 321 | HROW | Harrow, Inc. | 1.47B | 0.41% | 156,272 | 268.68M |
| 322 | VIR | Vir Biotechnology, Inc. | 1.47B | -4.06% | 1,531,401 | 303.23M |
| 323 | PAHC | Phibro Animal Health Corporation | 1.46B | -0.28% | 68,183 | 1.50B |
| 324 | SVRA | Savara Inc. | 1.46B | 4.17% | 485,064 | - |
| 325 | KMTS | Kestra Medical Technologies, Ltd. | 1.45B | -1.04% | 75,729 | 95.13M |
| 326 | XNCR | Xencor, Inc. | 1.43B | -2.72% | 471,136 | 104.97M |
| 327 | AVBP | ArriVent BioPharma, Inc. | 1.43B | 0.21% | 73,853 | - |
| 328 | PSNL | Personalis, Inc. | 1.42B | -1.63% | 1,024,280 | 69.67M |
| 329 | ATEC | Alphatec Holdings, Inc. | 1.41B | -4.70% | 1,971,548 | 815.05M |
| 330 | ABSI | Absci Corporation | 1.40B | -1.43% | 1,215,039 | 1.84M |
| 331 | AVLN | Avalyn Pharma Inc. | 1.40B | -1.56% | 63,850 | - |
| 332 | PNTG | The Pennant Group, Inc. | 1.38B | 2.40% | 180,289 | 1.10B |
| 333 | LBRX | LB Pharmaceuticals Inc | 1.38B | 6.62% | 317,719 | - |
| 334 | ALVO | Alvotech | 1.36B | 1.33% | 363,083 | 562.04M |
| 335 | IART | Integra LifeSciences Holdings Corporation | 1.35B | -1.64% | 156,150 | 1.65B |
| 336 | AZTA | Azenta, Inc. | 1.35B | -2.92% | 331,767 | 613.81M |
| 337 | AORT | Artivion, Inc. | 1.35B | 6.04% | 441,068 | 458.69M |
| 338 | SDGR | Schrödinger, Inc. | 1.34B | 9.57% | 1,841,935 | 259.04M |
| 339 | ORIC | ORIC Pharmaceuticals, Inc. | 1.33B | -0.54% | 429,405 | - |
| 340 | GLUE | Monte Rosa Therapeutics, Inc. | 1.33B | 0.96% | 545,264 | 28.73M |
| 341 | IMTX | Immatics N.V. | 1.31B | -2.05% | 189,845 | 43.00M |
| 342 | XERS | Xeris Biopharma Holdings, Inc. | 1.30B | -11.22% | 2,539,661 | 335.41M |
| 343 | AKTS | Aktis Oncology, Inc. | 1.30B | 3.80% | 158,996 | 8.28M |
| 344 | JBIO | Jade Biosciences, Inc. | 1.29B | 0.23% | 657,820 | - |
| 345 | TNDM | Tandem Diabetes Care, Inc. | 1.28B | -4.59% | 2,094,970 | 1.03B |
| 346 | VOR | Vor Biopharma Inc. | 1.27B | 4.87% | 313,726 | - |
| 347 | GDRX | GoodRx Holdings, Inc. | 1.26B | 14.07% | 3,090,422 | 785.23M |
| 348 | FRNM | Freenome, Inc. | 1.25B | 1.47% | 220,984 | 34.24M |
| 349 | ETON | Eton Pharmaceuticals, Inc. | 1.24B | -1.15% | 248,543 | 86.93M |
| 350 | NVAX | Novavax, Inc. | 1.24B | -1.82% | 3,545,070 | 413.80M |
| 351 | INBX | Inhibrx Biosciences, Inc. | 1.24B | 0.75% | 50,229 | 1.30M |
| 352 | CERT | Certara, Inc. | 1.23B | 0.87% | 1,057,014 | 421.75M |
| 353 | MNKD | MannKind Corporation | 1.22B | -6.46% | 6,882,739 | 393.63M |
| 354 | TDOC | Teladoc Health, Inc. | 1.22B | -2.96% | 2,472,789 | 2.49B |
| 355 | SPTX | Seaport Therapeutics, Inc. | 1.22B | 2.15% | 54,454 | - |
| 356 | ARDX | Ardelyx, Inc. | 1.22B | 0.61% | 1,849,327 | 427.68M |
| 357 | AMN | AMN Healthcare Services, Inc. | 1.21B | -5.18% | 440,734 | 3.42B |
| 358 | MGTX | MeiraGTx Holdings plc | 1.19B | 2.23% | 181,365 | 79.76M |
| 359 | WVE | Wave Life Sciences Ltd. | 1.19B | 1.60% | 909,803 | 65.37M |
| 360 | DRTS | Alpha Tau Medical Ltd. | 1.18B | -1.62% | 232,268 | - |
| 361 | IRMD | IRADIMED CORPORATION | 1.16B | -1.43% | 59,021 | 86.34M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 1.16B | -1.22% | 270,794 | - |
| 363 | BVS | Bioventus Inc. | 1.16B | -9.24% | 1,018,511 | 581.85M |
| 364 | USPH | U.S. Physical Therapy, Inc. | 1.16B | -2.17% | 316,160 | 804.27M |
| 365 | OMDA | Omada Health, Inc. | 1.15B | 1.15% | 965,030 | 283.30M |
| 366 | STAA | STAAR Surgical Company | 1.12B | -1.18% | 387,210 | 290.38M |
| 367 | AHG | Akso Health Group | 1.12B | -10.27% | 3,188 | 13.83M |
| 368 | QDEL | QuidelOrtho Corporation | 1.12B | -6.03% | 874,761 | 2.66B |
| 369 | ANRO | Alto Neuroscience, Inc. | 1.10B | 0.98% | 247,259 | - |
| 370 | PRCT | PROCEPT BioRobotics Corporation | 1.09B | -0.67% | 1,244,365 | 337.34M |
| 371 | LMRI | Lumexa Imaging Holdings, Inc. | 1.09B | 0.44% | 160,123 | 1.03B |
| 372 | APMD | Apnimed, Inc. | 1.08B | 2.00% | 154,447 | 120.15M |
| 373 | CGEM | Cullinan Therapeutics, Inc. | 1.07B | -0.97% | 264,257 | - |
| 374 | EYPT | EyePoint, Inc. | 1.07B | 3.92% | 1,573,938 | 2.79M |
| 375 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.06B | -2.24% | 3,666,945 | 41.47M |
| 376 | IVA | Inventiva S.A. | 1.06B | -1.48% | 237,420 | 7.94M |
| 377 | NUTX | Nutex Health Inc. | 1.06B | -2.38% | 91,314 | 879.95M |
| 378 | OLMA | Olema Pharmaceuticals, Inc. | 1.02B | 0.95% | 340,254 | - |
| 379 | SANA | Sana Biotechnology, Inc. | 1.02B | -3.13% | 1,022,971 | - |
| 380 | REPL | Replimune Group, Inc. | 1.02B | 2.28% | 1,610,920 | - |
| 381 | CRON | Cronos Group Inc. | 1.01B | 11.76% | 5,008,478 | 179.09M |
| 382 | ODTX | Odyssey Therapeutics, Inc. | 1.01B | 1.10% | 67,442 | 1.06M |
| 383 | PCRX | Pacira BioSciences, Inc. | 1.01B | 1.65% | 413,629 | 746.16M |
| 384 | GERN | Geron Corporation | 997.57M | -4.60% | 10,083,760 | 204.56M |
| 385 | OPK | OPKO Health, Inc. | 996.35M | -1.11% | 1,505,756 | 587.90M |
| 386 | JANX | Janux Therapeutics, Inc. | 974.53M | -0.12% | 142,400 | 13.73M |
| 387 | AVTX | Avalo Therapeutics, Inc. | 972.09M | -2.47% | 373,942 | 59.00K |
| 388 | COLL | Collegium Pharmaceutical, Inc. | 950.31M | -18.02% | 1,370,248 | 808.21M |
| 389 | GMRS | GMR Solutions Inc. | 943.81M | -0.70% | 127,445 | 5.83B |
| 390 | OMER | Omeros Corporation | 927.13M | 1.26% | 325,328 | 9.89M |
| 391 | CSTL | Castle Biosciences, Inc. | 911.60M | -1.84% | 199,608 | 357.28M |
| 392 | ATTO | Attovia Therapeutics, Inc. | 903.61M | -4.11% | 222,059 | 1.35M |
| 393 | ANNX | Annexon, Inc. | 901.95M | 2.51% | 1,754,278 | - |
| 394 | ABUS | Arbutus Biopharma Corporation | 885.96M | -2.92% | 699,620 | 191.45M |
| 395 | TBPH | Theravance Biopharma, Inc. | 877.97M | 0.24% | 143,690 | 109.78M |
| 396 | TALK | Talkspace, Inc. | 875.25M | 0.10% | 261,459 | 238.37M |
| 397 | SLDB | Solid Biosciences Inc. | 871.28M | 1.37% | 264,010 | - |
| 398 | AMPH | Amphastar Pharmaceuticals, Inc. | 869.51M | -2.57% | 235,458 | 720.53M |
| 399 | INMD | InMode Ltd. | 868.53M | -0.66% | 282,734 | 374.63M |
| 400 | GLAS | Glass House Brands Inc. | 851.98M | 2.59% | 200,575 | 177.68M |
| 401 | ACRS | Aclaris Therapeutics, Inc. | 851.95M | -4.09% | 2,007,711 | 8.37M |
| 402 | DSGN | Design Therapeutics, Inc. | 851.74M | 0.29% | 133,015 | - |
| 403 | DBVT | DBV Technologies S.A. | 830.24M | -8.01% | 664,121 | 5.04M |
| 404 | KURA | Kura Oncology, Inc. | 830.04M | 1.63% | 437,646 | 71.64M |
| 405 | SGP | SpyGlass Pharma, Inc. | 824.80M | 4.18% | 42,360 | - |
| 406 | AVR | Anteris Technologies Global Corp. | 822.52M | 4.84% | 680,734 | 1.85M |
| 407 | AURA | Aura Biosciences, Inc. | 818.42M | 3.34% | 262,543 | - |
| 408 | AHCO | AdaptHealth Corp. | 816.46M | -5.77% | 4,067,477 | 3.36B |
| 409 | HSTM | HealthStream, Inc. | 816.13M | -0.27% | 106,994 | 321.12M |
| 410 | MNPR | Monopar Therapeutics Inc. | 814.37M | 1.96% | 221,696 | - |
| 411 | SIBN | SI-BONE, Inc. | 800.01M | -1.05% | 197,550 | 213.60M |
| 412 | CLYM | Climb Bio, Inc. | 775.31M | 8.58% | 748,320 | - |
| 413 | PHAR | Pharming Group N.V. | 771.24M | 0.37% | 3,134 | 366.48M |
| 414 | DRUG | Bright Minds Biosciences Inc. | 766.86M | 1.74% | 97,042 | - |
| 415 | CADL | Candel Therapeutics, Inc. | 766.41M | - | 717,978 | - |
| 416 | TENX | Tenax Therapeutics, Inc. | 758.41M | 1.46% | 762,629 | - |
| 417 | OCS | Oculis Holding AG | 742.17M | 1.82% | 138,925 | 1.40M |
| 418 | SSII | SS Innovations International, Inc. | 738.49M | -4.16% | 11,267 | 48.47M |
| 419 | CTMX | CytomX Therapeutics, Inc. | 734.75M | 0.75% | 883,151 | 35.54M |
| 420 | RIGL | Rigel Pharmaceuticals, Inc. | 727.58M | -3.78% | 146,009 | 276.79M |
| 421 | NGNE | Neurogene Inc. | 711.39M | -0.78% | 47,107 | 925.00K |
| 422 | IMMX | Immix Biopharma, Inc. | 704.78M | 3.77% | 814,860 | - |
| 423 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 704.14M | -1.90% | 98,619 | - |
| 424 | GYRE | Gyre Therapeutics, Inc. | 703.49M | 1.28% | 13,727 | 117.05M |
| 425 | EVO | Evotec SE | 702.97M | -1.52% | 27,565 | 859.03M |
| 426 | PHR | Phreesia, Inc. | 701.56M | -1.22% | 347,852 | 495.59M |
| 427 | IRWD | Ironwood Pharmaceuticals, Inc. | 696.31M | 1.93% | 1,977,425 | 361.51M |
| 428 | CBLL | CeriBell, Inc. | 694.73M | 0.11% | 70,812 | 95.07M |
| 429 | RGNX | REGENXBIO Inc. | 689.22M | 6.38% | 1,079,883 | 174.48M |
| 430 | ZVRA | Zevra Therapeutics, Inc. | 684.55M | 9.97% | 1,537,412 | 136.07M |
| 431 | HELP | Cybin Inc. | 684.30M | 4.84% | 2,245,657 | - |
| 432 | CBIO | Crescent Biopharma, Inc. | 683.10M | 1.20% | 78,732 | 11.88M |
| 433 | AGMB | AgomAb Therapeutics NV | 680.85M | -3.46% | 21,108 | - |
| 434 | ALLO | Allogene Therapeutics, Inc. | 671.33M | -0.26% | 2,251,364 | 22.00K |
| 435 | ACHV | Achieve Life Sciences, Inc. | 670.36M | -1.95% | 345,793 | - |
| 436 | PHAT | Phathom Pharmaceuticals, Inc. | 663.24M | 1.46% | 914,726 | 239.66M |
| 437 | TCMD | Tactile Systems Technology, Inc. | 649.62M | -3.94% | 70,040 | 343.52M |
| 438 | BWAY | BrainsWay Ltd. | 638.93M | 4.33% | 82,508 | 56.22M |
| 439 | BBNX | Beta Bionics, Inc. | 632.11M | 1.01% | 244,979 | 119.01M |
| 440 | FTH | Faeth Therapeutics, Inc. | 625.13M | -1.38% | 158,211 | - |
| 441 | ANGO | AngioDynamics, Inc. | 624.12M | 0.40% | 105,903 | 320.17M |
| 442 | NVCT | Nuvectis Pharma, Inc. | 620.03M | -1.19% | 130,969 | - |
| 443 | TLRY | Tilray Brands, Inc. | 612.98M | 2.15% | 2,778,462 | 915.45M |
| 444 | MDXG | MiMedx Group, Inc. | 607.82M | 0.24% | 621,143 | 355.17M |
| 445 | MPLT | MapLight Therapeutics, Inc. | 599.92M | 2.40% | 213,988 | - |
| 446 | ALT | Altimmune, Inc. | 587.31M | -0.33% | 2,027,942 | 36.00K |
| 447 | CRMD | CorMedix Inc. | 586.04M | 0.81% | 307,478 | 400.05M |
| 448 | KIDS | OrthoPediatrics Corp. | 580.72M | -0.31% | 205,017 | 252.72M |
| 449 | CTNM | Contineum Therapeutics, Inc. | 566.57M | -1.38% | 93,688 | - |
| 450 | RLMD | Relmada Therapeutics, Inc. | 563.26M | -1.29% | 401,510 | - |
| 451 | TECX | Tectonic Therapeutic, Inc. | 562.49M | 0.85% | 32,023 | - |
| 452 | ARVN | Arvinas, Inc. | 560.36M | 2.02% | 1,974,384 | 316.70M |
| 453 | ARTV | Artiva Biotherapeutics, Inc. | 557.79M | -0.95% | 198,183 | 251.00K |
| 454 | SPRY | ARS Pharmaceuticals, Inc. | 552.13M | 3.73% | 750,780 | 98.99M |
| 455 | SOPH | SOPHiA GENETICS SA | 549.93M | 2.54% | 269,851 | 86.17M |
| 456 | DNA | Ginkgo Bioworks Holdings, Inc. | 549.38M | -10.25% | 1,060,718 | 132.42M |
| 457 | FDMT | 4D Molecular Therapeutics, Inc. | 545.76M | 1.56% | 152,818 | 88.24M |
| 458 | STTK | Shattuck Labs, Inc. | 542.13M | -4.07% | 390,992 | 1.00M |
| 459 | ZURA | Zura Bio Limited | 540.54M | 0.89% | 319,961 | - |
| 460 | SLN | Silence Therapeutics plc | 539.41M | 1.60% | 138,119 | 839.00K |
| 461 | SGMT | Sagimet Biosciences Inc. | 536.01M | 0.46% | 1,037,473 | - |
| 462 | CTKB | Cytek Biosciences, Inc. | 535.94M | -0.72% | 735,270 | 206.71M |
| 463 | PRME | Prime Medicine, Inc. | 534.63M | -3.90% | 1,561,594 | 4.07M |
| 464 | ANL | Adlai Nortye Ltd. | 527.60M | 0.92% | 226,985 | 5.00M |
| 465 | DCTH | Delcath Systems, Inc. | 521.00M | 19.49% | 2,215,740 | 95.42M |
| 466 | WEAV | Weave Communications, Inc. | 518.77M | -4.12% | 664,312 | 248.72M |
| 467 | VREX | Varex Imaging Corporation | 517.14M | -0.97% | 125,060 | 857.50M |
| 468 | AUTL | Autolus Therapeutics plc | 516.32M | 2.11% | 2,473,314 | 92.62M |
| 469 | VSTM | Verastem, Inc. | 510.55M | -1.02% | 816,234 | 49.59M |
| 470 | ASMB | Assembly Biosciences, Inc. | 509.57M | -0.24% | 51,873 | 71.10M |
| 471 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 472 | FLGT | Fulgent Genetics, Inc. | 503.94M | -1.16% | 121,994 | 323.93M |
| 473 | STLN | Starling Oncology, Inc. | 503.91M | 0.20% | 905,924 | 545.76M |
| 474 | PROK | ProKidney Corp. | 495.38M | -1.80% | 196,675 | 889.00K |
| 475 | EIKN | Eikon Therapeutics, Inc. | 494.29M | -4.40% | 244,594 | - |
| 476 | SRTA | Strata Critical Medical, Inc. | 493.64M | -4.62% | 714,757 | 255.98M |
| 477 | RZLT | Rezolute, Inc. | 488.90M | - | 615,057 | - |
| 478 | VALN | Valneva SE | 488.51M | -0.57% | 14,730 | 180.25M |
| 479 | SCTX | Scribe Therapeutics Inc. | 487.93M | 8.68% | 122,308 | 36.28M |
| 480 | OVID | Ovid Therapeutics Inc. | 486.20M | -0.57% | 797,726 | 7.12M |
| 481 | NPCE | NeuroPace, Inc. | 484.81M | 3.80% | 158,080 | 99.53M |
| 482 | QTTB | Q32 Bio Inc. | 482.18M | -1.76% | 439,825 | 53.74M |
| 483 | AQST | Aquestive Therapeutics, Inc. | 480.54M | 2.00% | 915,218 | 50.27M |
| 484 | EOLS | Evolus, Inc. | 478.11M | 17.48% | 2,039,761 | 316.49M |
| 485 | BIOA | BioAge Labs, Inc. | 475.64M | -2.55% | 397,534 | 10.36M |
| 486 | EVMN | Evommune, Inc. | 475.44M | 1.38% | 485,254 | 10.00M |
| 487 | KYTX | Kyverna Therapeutics, Inc. | 474.20M | 2.09% | 233,524 | - |
| 488 | IKT | Inhibikase Therapeutics, Inc. | 471.94M | 0.63% | 227,934 | 1.00 |
| 489 | CERS | Cerus Corporation | 469.55M | 2.64% | 1,512,529 | 221.55M |
| 490 | SI | Shoulder Innovations, Inc. | 467.44M | -0.27% | 13,975 | 53.89M |
| 491 | NNNN | Anbio Biotechnology | 458.66M | 2.96% | 11,786 | 8.65M |
| 492 | PRLD | Prelude Therapeutics Incorporated | 453.24M | 0.66% | 139,951 | 16.72M |
| 493 | EDIT | Editas Medicine, Inc. | 449.64M | 6.55% | 2,526,833 | 47.01M |
| 494 | BNTC | Benitec Biopharma Inc. | 449.35M | 3.07% | 26,403 | - |
| 495 | CABA | Cabaletta Bio, Inc. | 449.22M | 1.66% | 1,807,471 | - |
| 496 | LRMR | Larimar Therapeutics, Inc. | 440.50M | 2.93% | 506,197 | - |
| 497 | SLBT | SL Science Holding Limited | 440.14M | -2.74% | 23,457 | 3.27M |
| 498 | PRTA | Prothena Corporation plc | 436.89M | -1.71% | 165,729 | 57.94M |
| 499 | CTEV | Claritev Corporation | 431.82M | -3.06% | 17,052 | 978.76M |
| 500 | OFIX | Orthofix Medical Inc. | 428.55M | 0.97% | 252,096 | 833.19M |